Thursday, December 10, 2009

Another Insomnia Drug Bites the Dust – Somulin Still on Top

According to a recent report on Bloomberg.com – the Somaxon Pharmaceuticals Inc. has reported that their highly touted insomnia drug, Silenor, has been rejected once again by the FDA (US Food and Drug Administration), who cited concerns over the drug’s overall effectiveness, when weighed against other risks, such as the effect the drug can have on vital organs like the heart. This is just another drug to add to the stockpile of insomnia drugs that have failed before even hitting the marketplace—all trying to bid in competition of Ambien, one of the most popular prescribed sleeping drugs.

As you can see, there are good reasons why many Americans, and others around the world, are turning to alternative medicines to treat ailments such as insomnia. Concerns over the high costs of prescription drugs – in this case, Silenor costs hundreds of millions of dollars in research and development – their inherent interactions and side effects even when they are granted FDA approval, and costly doctor visits associated with their prescribing.

So where is the light at the end of the tunnel? How can you treat the symptoms of insomnia effectively, safely and naturally?

There is a plethora of amazing reasons why Somulin is the number one best-selling, all-natural sleep-aid in the world.

Learn more right now by visiting: www.Somulin.com